Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists

3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists

US Patent 11136328 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carm1 inhibitors and uses thereof2023
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiet2023
Arginine methyltransferase inhibitors and uses thereof2022
Arginine methyltransferase inhibitors and uses thereof2021
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiet2021
Arginine methyltransferase inhibitors and uses thereof2020
Arginine methyltransferase inhibitors and uses thereof2020
CARM1 inhibitors and uses thereof2020
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor an2020
Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists2019
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor an2019
PRMT1 inhibitors and uses thereof2019